Ghusun Mohammad Alhazimi

Ms. Ghusun Mohammad Alhazimi


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2026 in Infectious Disease Reports
Verified
Journal Article
Open access
PDF file
SHShuaibu Hudu
Shuaibu Hudu
EMEmad Abdelhamid Morad
Emad Abdelhamid Morad
GAGhusun Mohammad Alhazimi
Ghusun Mohammad Alhazimi
AJAbdulgafar Olayiwola Jimoh
Abdulgafar Olayiwola Jimoh
Arboviral diseases are emerging as important public health threats in Saudi Arabia, driven by rapid urbanization, climate variability, the expansion of Aedes aegypti populations, international travel, and large-scale religious mass gatherings. Dengue virus remains the most established arboviral infection in the Kingdom, particularly in the southwestern regions such as Jazan and the western urban centers of Makkah and Jeddah, where ecological and climatic conditions are conducive to sustained vector survival and transmission. This review synthesizes current evidence on the epidemiology, vector ecology, climatic determinants, diagnostics, and prevention strategies of arboviral diseases in Saudi Arabia. Particular attention is paid to the impacts of rising temperatures, changes in rainfall patterns, urban heat island effects, population mobility, and cross-border movement on vector expansion and disease emergence. The review also identifies gaps in surveillance, diagnostics, insecticide resistance monitoring, and integrated vector management programs. Emerging preparedness strategies include climate-informed early warning systems, Geographic Information System-based risk mapping, multiplex molecular diagnostics, genomic surveillance, and community-based vector control. The review emphasizes the importance of implementing a One Health approach that combines data on humans, the environment, entomology, and climate. Currently, sustained endemic transmission of chikungunya and Zika viruses has not been conclusively demonstrated in Saudi Arabia, but increased environmental suitability and connectivity with other areas highlight the need for proactive surveillance and preparedness.

25 August 2026 in Journal of the Formosan Medical Association
Verified
Journal Article
Open access
SHShuaibu Hudu
Shuaibu Hudu
EMEmad Abdelhamid Morad
Emad Abdelhamid Morad
GAGhusun Mohammad Alhazimi
Ghusun Mohammad Alhazimi
NSNaglaa Shalaby
Naglaa Shalaby
AJAbdulgafar Olayiwola Jimoh
Abdulgafar Olayiwola Jimoh

26 June 2026 in Diseases
Verified
Journal Article
Open access
PDF file
SHShuaibu Hudu
Shuaibu Hudu
MAMuhannad Alruwaili
Muhannad Alruwaili
MSMohamed Soliman
Mohamed Soliman
EMEmad Abdelhamid Morad
Emad Abdelhamid Morad
GAGhusun Mohammad Alhazimi
Ghusun Mohammad Alhazimi
AJAbdulgafar Olayiwola Jimoh
Abdulgafar Olayiwola Jimoh
Background: Messenger RNA (mRNA) vaccines have emerged as a versatile platform beyond SARS-CoV-2, with expanding applications in infectious diseases and oncology. However, comprehensive evidence synthesis of non-SARS-CoV-2 mRNA vaccines remains limited. Methods: This systematic review followed PRISMA 2020 guidelines and was registered in PROSPERO (CRD420261323500). MEDLINE, Embase, Web of Science, Scopus, ClinicalTrials.gov, and WHO ICTRP were systematically searched for studies published between 1 January 2000 and 28 February 2026. Eligible studies included phase I–III clinical trials and in vivo preclinical studies evaluating non-SARS-CoV-2 mRNA vaccines. Two reviewers independently screened studies, extracted data, and assessed risk of bias using RoB 2, ROBINS-I, and SYRCLE tools. Findings were synthesized narratively because of substantial heterogeneity. Results: A total of 40 studies met the eligibility criteria and were included in the review, comprising 20 clinical studies and 20 preclinical studies. Advanced clinical programs targeted influenza and respiratory syncytial virus (RSV), with phase III trials displaying seroconversion rates above 70% with good safety profiles. Preliminary phase I studies for HIV, cytomegalovirus, rabies, and personalized cancer mRNA vaccines showed promising humoral and cellular immune responses. Preclinical studies showed strong antibody and T-cell responses against malaria, tuberculosis, Group B Streptococcus, and Zika virus. Most adverse events were mild to moderate, while serious vaccine-related adverse events were uncommon. Conclusions: Non-SARS-CoV-2 mRNA vaccines demonstrate substantial translational potential across infectious disease and oncology applications. Although the vaccine candidates have demonstrated promising immunogenicity and safety, most are in the early stages of development. This highlights the need for large trials, long-term safety follow-up and better global representation.

27 May 2026 in Environments
Verified
Journal Article
Open access
PDF file
SHShuaibu Hudu
Shuaibu Hudu
EMEmad Abdelhamid Morad
Emad Abdelhamid Morad
GAGhusun Mohammad Alhazimi
Ghusun Mohammad Alhazimi
AJAbdulgafar Olayiwola Jimoh
Abdulgafar Olayiwola Jimoh
Antimicrobial resistance (AMR) is a global health threat that continues to concern scientists because it can be driven not only by antibiotic misuse but also by environmental factors. Mining-related heavy metal pollution can apply strong selective pressure on microbial communities, leading to a significant increase and spread of antibiotic resistance genes (ARGs) in the environmental ecosystems. Here, we critically review the emerging role of mining environments as hotspots of environmental resistomes and the mechanisms by which heavy metal contamination drives co-selection of antibiotic resistance. There is also evidence that mining environments, such as AMD systems, mine tailings, contaminated sediments, and mining-impacted soils, harbor highly diverse microbiomes enriched with different resistance determinants. Heavy metals such as copper, zinc, cadmium, mercury, and arsenic promote ARG co-selection through co-resistance, cross-resistance, and co-regulation mechanisms. Widespread co-occurrence of metal- and antibiotic-resistance genes on mobile genetic elements such as plasmids, integrons, and transposons has been demonstrated in metagenomic studies. Environmental dissemination pathways, such as water systems, agricultural soils, wildlife interactions, and occupational exposure, may promote the spread of resistance genes outside mining sites. Mining ecosystems are underrecognized and potentially important reservoirs of antimicrobial resistance. This review highlights the importance of integrating environmental resistome surveillance into existing global AMR monitoring frameworks to understand underlying ecological drivers of resistance evolution. Tackling metal-driven antibiotic resistance requires innovative, solution-based interdisciplinary research, enhanced environmental screening and soil and water testing practices, and sustainable mining practices within the One Health paradigm.

10 October 2026 in Journal of Xenobiotics
Verified
Journal Article
Open access
PDF file
SHShuaibu Hudu
Shuaibu Hudu
EMEmad Abdelhamid Morad
Emad Abdelhamid Morad
GAGhusun Mohammad Alhazimi
Ghusun Mohammad Alhazimi
RORashad Qasem Othman
Rashad Qasem Othman
YEYahia Abdelgawad Elsayed Elboraei
Yahia Abdelgawad Elsayed Elboraei
AJAbdulgafar Olayiwola Jimoh
Abdulgafar Olayiwola Jimoh
Mining environments are extreme subsurface ecosystems characterized by elevated concentrations of metals and minerals, limited light, and high particulate loads. Occupational health research in mining has traditionally emphasized physical and chemical hazards, whereas biological exposures remain less well-characterized. This narrative review synthesizes evidence on mining-associated microbial communities, bioaerosols, occupational exposure, respiratory health, and antimicrobial resistance (AMR). The literature search covered PubMed/MEDLINE, Scopus, and Web of Science from database inception through August 2026. Evidence from coal, uranium, metal mining, acid mine drainage, and mine dust environments indicates that geochemical conditions and mining activities shape microbial communities. Drilling, blasting, excavation, and ore transport can aerosolize microbial cells, spores, and dust-associated microbial components, creating plausible inhalation pathways. Metal-rich environments may also favor persistence and co-selection of metal- and antibiotic-resistance determinants within environmental microbial communities. Metagenomic sequencing and environmental DNA approaches have expanded detection of microbial diversity, functional genes, and environmental resistomes. However, environmental detection does not establish microbial viability, effective worker exposure, transmission, or disease causation. Future research should integrate standardized environmental and personal microbial exposure measurements with respirable dust and chemical monitoring, longitudinal occupational epidemiology, and functional validation of resistance determinants to determine the actual occupational-health significance of mining-associated microbiomes.